Prevalence of Helicobacter pylori in children and their family members in a district in Turkey.
Abdullah Ceylan, Ercan Kirimi, Oğuz Tuncer...
https://pubmed.ncbi.nlm.nih.gov/18402185Actively Recruiting
All Genders
ID06457334
Effect of Helicobacter Pylori Eradication on Gastroesophageal Reflux Disease (GERD)
Led by Assiut University · Updated on 2024-06-13
100
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Helicobacter pylori (H. pylori) is a common bacterium affecting up to half of the global population, especially in developing countries. Gastroesophageal reflux disease (GERD) is a chronic condition where stomach contents flow back into the esophagus, causing symptoms like heartburn and regurgitation. This trial investigates how eradicating H. pylori may impact GERD symptoms and disease severity, as the relationship between H. pylori infection and GERD is not fully understood. Participants diagnosed with GERD through clinical and endoscopic methods will be observed to assess the effects of H. pylori eradication. The study period spans from January 2024 to December 2024, during which researchers will monitor the success of triple therapy in eliminating H. pylori and evaluate changes in GERD symptoms following eradication. During the study, participants will undergo assessments to confirm H. pylori eradication and track GERD symptom improvement. The main outcomes measured are the eradication of H. pylori and the effect of this eradication on GERD symptoms over the year-long observation. The study is observational and does not involve experimental treatments beyond standard care.
CONDITIONS
Brief Title
Effect of Helicobacter Pylori Eradication on Gastroesophageal RefIux Disease (GERD)
Who Can Participate
All Genders
Eligibility Criteria
You may qualify if you...
- All patients diagnosed as GERD clinically and endoscopically.
You will not qualify if you...
- No exclusion criteria
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Diagnostic Evaluation
Duration - Up to 12 months
Participants diagnosed with GERD clinically and endoscopically are assessed for Helicobacter pylori infection and related symptoms.
Visits during the 12-month study period
Long-term Monitoring
Duration - Up to 12 months
Participants with GERD are observed to evaluate the effect of Helicobacter pylori eradication on GERD symptoms over time.
Visits during the 12-month study period
Trial Site Locations
Total: 1 location
1
Alrajhi Hospital
Asyut, Egypt
Actively Recruiting
Loading map...
Research Team
S
Sara F Abdelhamid elgamal, master
R
Rasha M Omar, lecturer
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here